Intermittent claudication is a potentially disabling disorder that impairs quality of life and is a marker of underlying cardiovascular disease. Treatment involves secondary prevention and measures to improve walking. Cilostazol significantly increases walking distance and quality of life in claudicants.
|Number of pages||4|
|Publication status||Published - 2004|
- PERIPHERAL ARTERIAL-DISEASE
- CARDIOVASCULAR EVENTS
- CONTROLLED TRIALS